ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Theravance Biopharma Inc

Theravance Biopharma Inc (TBPH)

9.59
-0.05
(-0.52%)
Al cierre: 05 Agosto 3:00PM
9.59
0.00
( 0.00% )
Fuera de horario: 4:26PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
9.59
Postura de Compra
9.60
Postura de Venta
10.40
Volume Operado de la Acción
362,946
9.24 Rango del Día 9.67
8.13 Rango de 52 semanas 11.71
Capitalización de Mercado [m]
Precio Anterior
9.64
Precio de Apertura
9.24
Última hora de negociación
15:05:03
Volumen financiero
US$ 3,451,785
Precio Promedio Ponderado
9.5105
Volumen promedio (3 m)
342,556
Acciones en circulación
48,633,224
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.43
Beneficio por acción (BPA)
-1.13
turnover
57.42M
Beneficio neto
-55.19M

Acerca de Theravance Biopharma Inc

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the area... Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. It develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
George Town, Cym
Fundado
1970
Theravance Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TBPH. The last closing price for Theravance Biopharma was US$9.64. Over the last year, Theravance Biopharma shares have traded in a share price range of US$ 8.13 to US$ 11.71.

Theravance Biopharma currently has 48,633,224 shares in issue. The market capitalisation of Theravance Biopharma is US$468.82 million. Theravance Biopharma has a price to earnings ratio (PE ratio) of -8.43.

TBPH Últimas noticias

Thor Energy PLC Quarterly Activities and Cash Flow Report

Thor Energy PLC 31 July 2024   31 July 2024   Thor Energy PLC   ("Thor" or the "Company")   Quarterly Activities and Cash Flow Report April to June 2024   Highlights Outlook for next quarter...

Thor Energy PLC Holding(s) in Company

Thor Energy PLC 19 July 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BRJ52319 Issuer Name THOR ENERGY PLC UK or Non-UK Issuer UK 2. Reason for...

Thor Energy PLC Change of Nominated Adviser and Broker

Thor Energy PLC 15 July 2024         Thor Energy PLC   ("Thor" or the "Company")   Change of Nominated Adviser and Broker   The Company announces its Nominated Adviser and Broker has changed...

Thor Energy PLC Holding(s) in Company

Thor Energy PLC 09 July 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

TRADING UPDATES: Thor Energy drilling starts; Deltic accepts licence

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Al ...

Thor Energy PLC Drilling Commences

Thor Energy PLC 08 July 2024   8 July 2024 Thor Energy PLC   ("Thor" or the "Company")   Drilling Commences Alford West Copper ISR Project, South Australia   The directors of Thor Energy Plc...

Thor Energy PLC Director/PDMR Shareholding

Thor Energy PLC 28 June 2024   28 June 2024 Thor Energy Plc   ("Thor" or the "Company")   Director/PDMR Shareholding   The Directors of Thor Energy Plc (AIM, ASX: THR) announce that two...

Thor Energy touts promising sampling results at Edna Mae prospect

Thor Energy PLC on Monday said that uranium-vanadium assay results from the Edna Mae prospect had shown the presence ...

Thor Energy PLC Mineralisation at Edna Mae Prospect

Thor Energy PLC 24 June 2024   24 June 2024 Thor Energy PLC   ("Thor" or the "Company)    Sampling returns up to 5,424ppm (0.54 %) U3O8, 1.6 % V2O5 and 2.74 % Cu. Edna Mae Prospect- Wedding...

Thor Energy PLC Result of General Meeting and Total Voting Right

Thor Energy PLC 20 June 2024   20 June 2024   Thor Energy PLC   ("Thor" or the "Company")   Result of General Meeting and Total Voting Right The directors of Thor Energy Plc ("Thor") (AIM...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.64-6.2561094819210.2310.359.2429701210.00377352CS
40.778.730158730168.8210.428.653537719.71871869CS
120.111.160337552749.4810.428.133425569.08444321CS
260.778.730158730168.8210.448.133736249.06026507CS
52-0.39-3.907815631269.9811.718.133971149.49959151CS
156-3.35-25.888717156112.9414.286.16934669.60601098CS
260-10.53-52.335984095420.1231.546.155115112.34203636CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
LYTLytus Technologies Holdings PTV Ltd
US$ 1.90
(34.75%)
1.31M
SMXSMX Security Matters Public Company
US$ 3.90
(20.00%)
114k
HOVRNew Horizon Aircraft Ltd
US$ 0.62
(17.36%)
102k
BIAFbioAffinity Technologies Inc
US$ 1.92
(16.36%)
735
EVEREverQuote Inc
US$ 27.68
(15.53%)
55.71k
AQMSAqua Metals Inc
US$ 0.21
(-29.53%)
304.05k
TDUPThredUp Inc
US$ 1.31
(-24.28%)
61.42k
CONNConns Inc
US$ 0.078
(-20.00%)
435.34k
TENKTenX Keane Acquisition
US$ 31.01
(-14.00%)
60.28k
NCNCnoco noco Inc
US$ 0.1632
(-13.05%)
24.59k
PRSTPresto Technologies Inc
US$ 0.0301
(10.26%)
9.64M
NVDANVIDIA Corporation
US$ 102.07
(1.61%)
7.67M
SQQQProShares UltraPro Short QQQ
US$ 10.50
(-2.69%)
6.32M
LCIDLucid Group Inc
US$ 3.25
(8.33%)
6.19M
AGRIAgriFORCE Growing Systems Ltd
US$ 0.0651
(13.22%)
5.53M

TBPH Discussion

Ver más
Monksdream Monksdream 3 meses hace
TBPH underb$10

👍️0
ok2buy ok2buy 3 años hace
On the move back up. Smart money is, has been accumulating. About 85 % of the stock is held by institutions. Should not disappoint./ok2
👍️0
ok2buy ok2buy 3 años hace
May have bought a little too early, but hopefully Friday's move back up is a signal the bottom is in. Best of luck to the longs./ok2
👍️0
ok2buy ok2buy 3 años hace
Put my money where my mouth is, filled my order below $9.50. Best of luck to the longs./ok2
👍️0
ok2buy ok2buy 3 años hace
Missed their end point in the Phase IIB study, but still think there is value here. Selling off today as a result, but company looking at numbers, more to come I believe with a couple other drugs still in the pipeline. Institutional ownership is high on this one also, over 80 %. Big boys don't look to lose their $. Could be oversold, may be a buying opportunity here at today's prices./ok2
👍️0
PennyStock Alert PennyStock Alert 5 años hace
Dark stuff just hit the fan
👍️0
ValueInvestor15 ValueInvestor15 8 años hace
Baird downgraded Theravance $TBPH to Underperform. Wow this analysis shows huge downside: analysis

👍️0
stocktrademan stocktrademan 8 años hace
TBPH bullish 36.73



normal chart


log chart

👍️0
stocktrademan stocktrademan 9 años hace
$TBPH recent news/filings

bullish
close > 1 and average volume > 100k
bullish divergence breakout
double bottom




Theravance Biopharma, Inc.
Ugland House
South Church Street
George Town, KY1-1104
Cayman Islands
Phone: 650-808-6000
Website: http://www.theravance.com
Investors: http://investor.theravance.com/index.cfm

Theravance Biopharma, Inc. engages in the research and development activities focusing on the diseases of the lung and gastrointestinal tract, and infectious diseases, as well as on the acute care setting markets. The company offers VIBATIV, a bactericidal, once-daily injectable antibiotic to treat patients with infections due to Staphylococcus aureus and other Gram-positive bacteria. The company's TD-4208, an investigational long-acting muscarinic antagonist, which has completed Phase IIb study for the treatment of chronic obstructive pulmonary disease; and Axelopran, an investigational, once-daily, and oral peripherally active mu opioid receptor antagonist that is in Phase II clinical trial for opioid-induced constipation. It also offers Velusetrag, an oral and investigational medicine, which has completed first Phase II study for gastrointestinal motility disorders. The company focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol; the MABA program, as monotherapy; and in combination with other therapeutically active components, such as an inhaled corticosteroid. Theravance Biopharma, Inc. is incorporated in 2013 and is based in George Town, the Cayman Islands.

## source: finance.yahoo.com

Fri, 28 Aug 2015 20:40:14 GMT ~ THERAVANCE BIOPHARMA, INC. Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements


read full: http://biz.yahoo.com/e/150828/tbph8-k_a.html
*********************************************************

Thu, 27 Aug 2015 20:54:01 GMT ~ Theravance Biopharma to Present at the Baird 2015 Healthcare Conference

[at noodls] - August 27, 2015 DUBLIN, IRELAND -- (Marketwired) -- 08/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Chairman and Chief Executive Officer and other members ...

read full: http://www.noodls.com/view/609191CD7421533E3C9DB7BBB33B028E6B0488CC
*********************************************************

Thu, 27 Aug 2015 20:30:00 GMT ~ Theravance Biopharma to Present at the Baird 2015 Healthcare Conference

[Marketwired] - Theravance Biopharma, Inc. announced today that Rick E Winningham, Chairman and Chief Executive Officer and other members of the management team will participate in a fireside chat at the Baird 2015 Healthcare ...

read full: http://finance.yahoo.com/news/theravance-biopharma-present-baird-2015-203000731.html
*********************************************************

Thu, 27 Aug 2015 17:04:19 GMT ~ THERAVANCE BIOPHARMA, INC. Financials


read full: http://finance.yahoo.com/q/is?s=tbph
*********************************************************

Wed, 19 Aug 2015 12:37:12 GMT ~ Theravance Biopharma (TBPH) in Focus: Stock Rises 5.9%


read full: http://finance.yahoo.com/news/theravance-biopharma-tbph-focus-stock-123712233.html
*********************************************************

$TBPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$TBPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/TBPH/company-info
Ticker: $TBPH
OTC Market Place: Not Available
CIK code: not found
Company name: Theravance Biopharma, Inc.
Incorporated In:

$TBPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$TBPH extra dd links

Company name: Theravance Biopharma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TBPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TBPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TBPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/news - http://finance.yahoo.com/q/h?s=TBPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TBPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TBPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TBPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Theravance+Biopharma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Theravance+Biopharma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Theravance+Biopharma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TBPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TBPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TBPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TBPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TBPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TBPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TBPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TBPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TBPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TBPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TBPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TBPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TBPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TBPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TBPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TBPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TBPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TBPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TBPH



$TBPH DD Notes ~ http://www.ddnotesmaker.com/TBPH
👍️0
NathanH NathanH 10 años hace
Test
👍️0

Su Consulta Reciente

Delayed Upgrade Clock